As of 2024-12-13, the EV/EBITDA ratio of Karo Pharma AB (KARO.ST) is 491.16. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. KARO.ST's latest enterprise value is 24,854.98 mil SEK. KARO.ST's TTM EBITDA according to its financial statements is 50.60 mil SEK. Dividing these 2 quantities gives us the above KARO.ST EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative Enterprise Value.
| Range | Selected | |
| Trailing P/E multiples | 5.3x - 6.5x | 5.9x |
| Forward P/E multiples | 5.9x - 6.8x | 6.2x |
| Fair Price | (29.68) - (23.57) | (26.87) |
| Upside | -149.2% - -139.1% | -144.6% |
| Date | EV/EBITDA |